260 related articles for article (PubMed ID: 27542090)
1. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score.
Sinclair M; Gow PJ; Grossmann M; Shannon A; Hoermann R; Angus PW
Liver Transpl; 2016 Nov; 22(11):1482-1490. PubMed ID: 27542090
[TBL] [Abstract][Full Text] [Related]
2. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
3. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study.
Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC
Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053
[TBL] [Abstract][Full Text] [Related]
4. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
5. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease.
Sinclair M; Grossmann M; Angus PW; Hoermann R; Hey P; Scodellaro T; Gow PJ
J Gastroenterol Hepatol; 2016 Mar; 31(3):661-7. PubMed ID: 26414812
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis.
Kalra A; Wedd JP; Bambha KM; Gralla J; Golden-Mason L; Collins C; Rosen HR; Biggins SW
Liver Transpl; 2017 Feb; 23(2):155-165. PubMed ID: 28006875
[TBL] [Abstract][Full Text] [Related]
7. Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes.
Apostolov R; Wong D; Low E; Vaz K; Spurio J; Worland T; Liu D; Chan RK; Gow P; Grossmann M; Sinclair M
Scand J Gastroenterol; 2023; 58(11):1328-1334. PubMed ID: 37282344
[TBL] [Abstract][Full Text] [Related]
8. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
9. Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.
Kerbert AJ; Weil D; Verspaget HW; Moréno JP; van Hoek B; Cervoni JP; Di Martino V; Coenraad MJ; Thevenot T
Liver Int; 2016 Apr; 36(4):530-7. PubMed ID: 26502363
[TBL] [Abstract][Full Text] [Related]
10. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
11. Low-serum testosterone levels pre-liver transplantation are associated with reduced rates of early acute allograft rejection in men.
Sinclair M; Angus PW; Gow PJ; Hoermann R; Mogilevski T; Grossmann M
Transplantation; 2014 Oct; 98(7):788-92. PubMed ID: 24918618
[TBL] [Abstract][Full Text] [Related]
12. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
13. Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.
Lin BC; Fang JF; Wong YC; Hwang TL; Hsu YP
Injury; 2012 Sep; 43(9):1457-61. PubMed ID: 21511254
[TBL] [Abstract][Full Text] [Related]
14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
15. High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease.
Sinclair M; Gow PJ; Angus PW; Hoermann R; Handelsman DJ; Wittert G; Martin S; Grossmann M
Liver Int; 2016 Nov; 36(11):1619-1627. PubMed ID: 26998685
[TBL] [Abstract][Full Text] [Related]
16. Serum sodium predicts mortality in patients listed for liver transplantation.
Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
[TBL] [Abstract][Full Text] [Related]
17. Plasma copeptin, a possible prognostic marker in cirrhosis.
Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
[TBL] [Abstract][Full Text] [Related]
18. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
19. Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
Kerbert AJ; Verbeke L; Chiang FW; Laleman W; van der Reijden JJ; van Duijn W; Nevens F; Wolterbeek R; van Hoek B; Verspaget HW; Coenraad MJ
PLoS One; 2015; 10(9):e0138264. PubMed ID: 26378453
[TBL] [Abstract][Full Text] [Related]
20. Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.
Mathur S; Gane EJ; McCall JL; Plank LD
J Gastroenterol Hepatol; 2008 Feb; 23(2):239-43. PubMed ID: 17489965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
